Distinct biological profiles associated with the risk of short-term relapse and mid/long-term relapse in Crohn’s disease patients stopping infliximab.

Pierre N. (2023 Mar 2), Distinct biological profiles associated with the risk of short-term relapse and mid/long-term relapse in Crohn’s disease patients stopping infliximab, Oral plenary session presentation at ECCO 2023.
DOI: 10.1093/ecco-jcc/jjac190.0002

For more information: BIOCYCLE website: biocycle-project.eu EU reference: grant agreement No 633168 – BIOCYCLE (PHC-13-2014).

16 Distinct biological profiles with the rick of relapse in Crohn’s disease-ECCO 2023